{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["36(8)"],"submitter":["Hirokami J"],"funding":["The EU-PORIA registry was supported by a research grant from Boston Scientific."],"pubmed_abstract":["<h4>Background</h4>Real-life data on efficacy and safety of pulsed-field ablation (PFA) using the pentaspline multi-electrode catheter in symptomatic atrial fibrillation (AF) patients is still scarce.<h4>Objective</h4>This study aims to assess the efficacy and safety of PFA in patients with persistent AF.<h4>Methods</h4>Data from early commercial use across seven European centers were collected in a registry. To confirm the efficacy and safety of extra pulmonary vein (PV) ablation, patients were categorized into two groups: those undergoing pulmonary vein isolation (PVI) alone and those receiving additional ablation. Procedural and follow-up data were collected.<h4>Results</h4>The study included 448 patients (347 PVI only, 101 PVI + α). In the PVI + α group, extra PV ablation included left"],"journal":["Journal of cardiovascular electrophysiology"],"pagination":["1710-1720"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12337630"],"repository":["biostudies-literature"],"pubmed_title":["Pulsed-Field Ablation for Persistent Atrial Fibrillation in EU-PORIA Registry."],"pmcid":["PMC12337630"],"pubmed_authors":["Tohoku S","Adelino R","Schmidt B","Futing A","Mene R","Reinsch N","Blaauw Y","Hirokami J","Reichlin T","Ouss A","Bordignon S","van der Voort P","Ruwald MH","Roten L","Boveda S","Chun KRJ","Mulder BA","Kueffer T","Albrecht EM","Hansen J","Neven K"],"additional_accession":[]},"is_claimable":false,"name":"Pulsed-Field Ablation for Persistent Atrial Fibrillation in EU-PORIA Registry.","description":"<h4>Background</h4>Real-life data on efficacy and safety of pulsed-field ablation (PFA) using the pentaspline multi-electrode catheter in symptomatic atrial fibrillation (AF) patients is still scarce.<h4>Objective</h4>This study aims to assess the efficacy and safety of PFA in patients with persistent AF.<h4>Methods</h4>Data from early commercial use across seven European centers were collected in a registry. To confirm the efficacy and safety of extra pulmonary vein (PV) ablation, patients were categorized into two groups: those undergoing pulmonary vein isolation (PVI) alone and those receiving additional ablation. Procedural and follow-up data were collected.<h4>Results</h4>The study included 448 patients (347 PVI only, 101 PVI + α). In the PVI + α group, extra PV ablation included left","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-04-30T14:41:40.197Z","creation":"2026-04-07T16:03:36.263Z"},"accession":"S-EPMC12337630","cross_references":{"pubmed":["40171797"],"doi":["10.1111/jce.16583"]}}